CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Qiagen N v   (NYSE: QGEN)
Other Ticker:  
 
 

QGEN's Capital Expenditures Growth by Quarter and Year

Qiagen N V 's Capital Expenditures results by quarter and year

 



QGEN Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 171.24 162.80 149.34 206.53
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   171.24 162.80 149.34 206.53

QGENs Annual Capital Expenditures
Qiagen N V 's Capital Expenditures in the fiscal year 2024 $ 171.24 millions
Qiagen N V 's Capital Expenditures in the fiscal year 2023 $ 162.80 millions
Qiagen N V 's Capital Expenditures in the fiscal year 2022 $ 0.00 millions
Qiagen N V 's Capital Expenditures in the fiscal year 2021 $ 206.53 millions
Qiagen N V 's Capital Expenditures in the fiscal year 2019 $ 274.88 millions




QGEN Capital Expenditures forth quarter 2024 Y/Y Growth Comment
Qiagen N v achieved in the forth quarter 2024, above Company average Capital Expenditures improvement of 5.19% year on year, to $ 171.24 millions.

Looking into forth quarter 2024 results within Biotechnology & Pharmaceuticals industry 26 other companies have achieved higher Capital Expenditures growth. While Qiagen N V ' s Capital Expenditures increase of 5.19% ranks overall at the positon no. 1276 in the forth quarter 2024.


QGEN Capital Expenditures ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 5.19 % 9.01 % -27.69 % -24.87 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   5.19 % 9.01 % -27.69 % -24.87 %

Financial Statements
Qiagen N V 's forth quarter 2024 Capital Expenditures $ 171.24 millions QGEN's Income Statement
Qiagen N V 's forth quarter 2023 Capital Expenditures $ 162.80 millions Quarterly QGEN's Income Statement


QGEN Capital Expenditures (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   5.19 % 9.01 % -27.69 % -24.87 %


Suppliers by QGEN Divisions >> Back to QGEN Growth rate Comparisons >>


Capital Expenditures forth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #27
Healthcare Sector #194
Overall #1276

Capital Expenditures Y/Y Growth Statistics
High Average Low
82.32 % -1.66 % -100 %
(Dec 31 2019)   0
Capital Expenditures forth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #27
Healthcare Sector #194
Overall #1276
Capital Expenditures Y/Y Growth Statistics
High Average Low
82.32 % -1.66 % -100 %
(Dec 31 2019)   0

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Qiagen N V 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QGEN's IV. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QGEN's IV. Quarter Q/Q Capital Expenditures Comment


Qiagen N V 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
0		 12 Months Ending
0
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #


Cumulative Capital Expenditures growth Comment
In the Dec 31 2024 period, Qiagen N V 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Qiagen N v achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2024 period, Qiagen N V 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Qiagen N v achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
QGEN's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for QGEN's Competitors
Capital Expenditures Growth for Qiagen N V 's Suppliers
Capital Expenditures Growth for QGEN's Customers

You may also want to know
QGEN's Annual Growth Rates QGEN's Profitability Ratios QGEN's Asset Turnover Ratio QGEN's Dividend Growth
QGEN's Roe QGEN's Valuation Ratios QGEN's Financial Strength Ratios QGEN's Dividend Payout Ratio
QGEN's Roa QGEN's Inventory Turnover Ratio QGEN's Growth Rates QGEN's Dividend Comparisons



Companies with similar Capital Expenditures increase for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2024
Ge Healthcare Technologies Inc 8.51%$ 8.511 millions
Teva Pharmaceutical Industries Limited8.40%$ 8.403 millions
Chemed Corporation8.34%$ 8.337 millions
Abcellera Biologics Inc 8.31%$ 8.309 millions
Passage Bio Inc 7.69%$ 7.692 millions
Organon and Co 7.41%$ 7.407 millions
Davita Inc 7.35%$ 7.349 millions
Nevro Corp 6.98%$ 6.982 millions
Cingulate Inc 6.15%$ 6.152 millions
Qiagen N v 5.18%$ 5.184 millions
Envista Holdings Corporation4.88%$ 4.878 millions
Sharps Technology Inc 4.83%$ 4.834 millions
Replimune Group Inc 4.71%$ 4.712 millions
Select Medical Holdings Corp4.66%$ 4.663 millions
Psychemedics Corporation4.00%$ 4.000 millions
Boston Scientific Corporation3.75%$ 3.745 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com